Madrigal Pharmaceuticals (MDGL) Non Operating Income (2025 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Non Operating Income of -$2.1 million for Q1 2026, down 1534.38% quarter-over-quarter from -$128000.0 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Non Operating Income (2025 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 2 years of Non Operating Income data on file, last reported at -$2.1 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$2.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (changed N/A YoY), and the FY2025 annual result was -$463000.0, changed N/A from the prior year.
- Non Operating Income declined to -$2.1 million in Q1 2026 per MDGL's latest filing, from -$128000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at -$42000.0 in Q2 2025 and troughed at -$2.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | -2.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.09 Mn |
| Dec 31, 2025 | -128,000.00 |
| Sep 30, 2025 | -293,000.00 |
| Jun 30, 2025 | -42,000.00 |